Arrhythmogenesis and COVID-19

Cardiol Rev. 2021 Nov-Dec;29(6):289-291. doi: 10.1097/CRD.0000000000000407.

Abstract

The ongoing coronavirus infection-2019 (COVID-19) global pandemic has had devastating impacts on the global population since 2019. Cardiac complications are a well-documented sequala of COVID-19, with exposed patients experiencing complications such as myocardial infarction, myocarditis, and arrythmias. This article aims to review prominent literature regarding COVID-19 and its link with arrhythmias, as well as to discuss some of the possible mechanisms by which arrhythmogenesis may occur in patients with COVID-19.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Antirheumatic Agents / adverse effects
  • Arrhythmias, Cardiac / chemically induced
  • Arrhythmias, Cardiac / epidemiology*
  • Arrhythmias, Cardiac / physiopathology
  • Azithromycin / adverse effects
  • COVID-19 / epidemiology*
  • COVID-19 / physiopathology
  • COVID-19 Drug Treatment
  • Humans
  • Hydroxychloroquine / adverse effects
  • Intensive Care Units
  • SARS-CoV-2
  • Severity of Illness Index

Substances

  • Anti-Bacterial Agents
  • Antirheumatic Agents
  • Hydroxychloroquine
  • Azithromycin